Drug intelligence / Profile preview

technetium-99m-labeled E48 F(ab')2

Development stage
Preclinical
Lead developer
Vrije University Medical Center
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium-99m-labeled E48 F(ab')2 is an investigational **radioimmunoscintigraphy agent** comprising the F(ab')2 antigen-binding fragment of the murine monoclonal antibody E48 labeled with technetium-99m. It binds lymphocyte antigen 6 family member D, historically called the E48 antigen, a glycosylphosphatidylinositol-anchored surface protein expressed in stratified squamous and transitional epithelia and their corresponding tumors. The agent was administered intravenously for planar gamma-camera and SPECT imaging of primary tumors and cervical lymph-node metastases in head and neck squamous cell carcinoma. It was evaluated clinically as a diagnostic imaging tracer rather than as a therapeutic radiopharmaceutical.

Other names
99mTc-labeled E48 F(ab')299mTc-labeled monoclonal antibody E48 F(ab')2technetium-99m-labeled monoclonal antibody E48 F(ab')2
02

Targets

LY6D (Lymphocyte antigen 6 complex locus D)

Beyond the preview

Go deeper on technetium-99m-labeled E48 F(ab')2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium-99m-labeled E48 F(ab')2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call